These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32143276)

  • 21. The N-terminal p.(Ser38Cys) TIMP3 mutation underlying Sorsby fundus dystrophy is a founder mutation disrupting an intramolecular disulfide bond.
    Naessens S; De Zaeytijd J; Syx D; Vandenbroucke RE; Smeets F; Van Cauwenbergh C; Leroy BP; Peelman F; Coppieters F
    Hum Mutat; 2019 May; 40(5):539-551. PubMed ID: 30668888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy.
    Weber BH; Vogt G; Pruett RC; Stöhr H; Felbor U
    Nat Genet; 1994 Dec; 8(4):352-6. PubMed ID: 7894485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late-Stage Sorsby Fundus Dystrophy Manifesting Severe Vision Loss in the Absence of Choroidal Neovascularization.
    Hanif AM; Jain N
    Ophthalmic Surg Lasers Imaging Retina; 2019 Aug; 50(8):e215-e217. PubMed ID: 31415707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review: Mechanisms of TIMP-3 accumulation and pathogenesis in Sorsby fundus dystrophy.
    Betts JHJ; Troeberg L
    Mol Vis; 2024; 30():74-91. PubMed ID: 38601018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of an induced pluripotent stem cell line (SJTUGHi003-A) from a patient with Sorsby fundus dystrophy carrying c.484G>A mutation in TIMP3 gene.
    Zhu X; Tang L; Zhang T; Bai X; Chen J; Zhang L; Gong Y; Jiang M; Sun X
    Stem Cell Res; 2024 Jun; 77():103423. PubMed ID: 38640637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sorsby Fundus Dystrophy: Novel Mutations, Novel Phenotypic Characteristics, and Treatment Outcomes.
    Gliem M; Müller PL; Mangold E; Holz FG; Bolz HJ; Stöhr H; Weber BH; Charbel Issa P
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2664-76. PubMed ID: 25766588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rare penetrant TIMP3 mutation confers relatively late onset choroidal neovascularisation which can mimic age-related macular degeneration.
    Warwick A; Gibson J; Sood R; Lotery A
    Eye (Lond); 2016 Mar; 30(3):488-91. PubMed ID: 26493035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galectin-1 promotes choroidal neovascularization and subretinal fibrosis mediated via epithelial-mesenchymal transition.
    Wu D; Kanda A; Liu Y; Kase S; Noda K; Ishida S
    FASEB J; 2019 Feb; 33(2):2498-2513. PubMed ID: 30277820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells.
    Langton KP; McKie N; Smith BM; Brown NJ; Barker MD
    Hum Mol Genet; 2005 Dec; 14(23):3579-86. PubMed ID: 16223891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early-Onset TIMP3-Related Retinopathy Associated With Impaired Signal Peptide.
    Guan B; Huryn LA; Hughes AB; Li Z; Bender C; Blain D; Turriff A; Cukras CA; Hufnagel RB
    JAMA Ophthalmol; 2022 Jul; 140(7):730-733. PubMed ID: 35679059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antiangiogenic therapy in Sorsby's fundus dystrophy without a mutation in the TIMP-3 gene].
    Copete-Piqueras S; Cava-Valenciano C; Flores-Moreno I; Moreno-Valladares A; Bautista Ruescas V
    Arch Soc Esp Oftalmol; 2013 Jun; 88(6):240-3. PubMed ID: 23726310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy.
    Felbor U; Stöhr H; Amann T; Schönherr U; Apfelstedt-Sylla E; Weber BH
    J Med Genet; 1996 Mar; 33(3):233-6. PubMed ID: 8728699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy.
    Saihan Z; Li Z; Rice J; Rana NA; Ramsden S; Schlottmann PG; Jenkins SA; Blyth C; Black GC; McKie N; Webster AR
    Mol Vis; 2009 Jun; 15():1218-30. PubMed ID: 19536307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of Gut Microbiota Is Associated with RPE/Choroid Transcriptomic Changes Related to Age-Related Macular Degeneration Pathobiology and Decreased Choroidal Neovascularization.
    Zhang JY; Xie B; Barba H; Nadeem U; Movahedan A; Deng N; Spedale M; D'Souza M; Luo W; Leone V; Chang EB; Theriault B; Sulakhe D; Skondra D
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sorsby's fundus dystrophy. A genetically homogeneous disease].
    Felbor U; Weber BH
    Ophthalmologe; 1998 May; 95(5):287-90. PubMed ID: 9643018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sorsby's fundus dystrophy in a family with a Ser-181-CVS mutation in the TIMP-3 gene: poor outcome after laser photocoagulation.
    Sieving PA; Boskovich S; Bingham E; Pawar H
    Trans Am Ophthalmol Soc; 1996; 94():275-94; discussion 295-7. PubMed ID: 8981701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease-Causing
    Vergaro A; Pankievic M; Jedlickova J; Dudakova L; Vajter M; Michaelides M; Meliska M; Nemec P; Babincova D; Kousal B; Liskova P
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sorsby fundus dystrophy with polypoidal choroidal vasculopathy: Extending TIMP3 phenotypes.
    Koutresi D; Clarke B; Lotery AJ; De Salvo G
    Clin Exp Ophthalmol; 2019 Dec; 47(9):1214-1218. PubMed ID: 31369189
    [No Abstract]   [Full Text] [Related]  

  • 39. Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels.
    Ablonczy Z; Dahrouj M; Marneros AG
    FASEB J; 2014 May; 28(5):2369-79. PubMed ID: 24558195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells.
    Majid MA; Smith VA; Easty DL; Baker AH; Newby AC
    Br J Ophthalmol; 2002 Jan; 86(1):97-101. PubMed ID: 11801512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.